Report Cover

Global and China OTC Anti-Infective Products Market Insights, Forecast to 2027


OTC Anti-Infective Products market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global OTC Anti-Infective Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the OTC Anti-Infective Products market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
    Antifungals
    Antiseptic
    Antiparasitics

Segment by Application
    Hospital Pharmacies
    Drug Stores
    Retail Stores
    E-Commerce

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

By Company
    GlaxoSmithKline
    Merck
    Pfizer
    Novartis
    Abbott
    Sanofi
    Bristol-Myers Squibb
    Roche
    NanoViricides
    Novabay Pharmaceuticals
    Optimer Pharmaceuticals
    Basilea Pharmaceutica
    MerLion Pharma
1 Study Coverage
    1.1 OTC Anti-Infective Products Product Introduction
    1.2 Market by Type
        1.2.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type
        1.2.2 Antifungals
        1.2.3 Antiseptic
        1.2.4 Antiparasitics
    1.3 Market by Application
        1.3.1 Global OTC Anti-Infective Products Market Size Growth Rate by Application
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 Retail Stores
        1.3.5 E-Commerce
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global OTC Anti-Infective Products Market Size, Estimates and Forecasts
        2.1.1 Global OTC Anti-Infective Products Revenue 2016-2027
        2.1.2 Global OTC Anti-Infective Products Sales 2016-2027
    2.2 Global OTC Anti-Infective Products, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 OTC Anti-Infective Products Historical Market Size by Region (2016-2021)
        2.3.1 Global OTC Anti-Infective Products Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global OTC Anti-Infective Products Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 OTC Anti-Infective Products Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global OTC Anti-Infective Products Sales Forecast by Region (2022-2027)
        2.4.2 Global OTC Anti-Infective Products Revenue Forecast by Region (2022-2027)

3 Global OTC Anti-Infective Products Competitor Landscape by Players
    3.1 Global Top OTC Anti-Infective Products Manufacturers by Sales
        3.1.1 Global OTC Anti-Infective Products Sales by Manufacturer (2016-2021)
        3.1.2 Global OTC Anti-Infective Products Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top OTC Anti-Infective Products Manufacturers by Revenue
        3.2.1 Key OTC Anti-Infective Products Manufacturers Covered: Ranking by Revenue
        3.2.2 Global OTC Anti-Infective Products Revenue by Manufacturers (2016-2021)
        3.2.3 Global OTC Anti-Infective Products Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global OTC Anti-Infective Products Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2020
        3.2.6 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global OTC Anti-Infective Products Price by Manufacturers
    3.4 Global OTC Anti-Infective Products Manufacturing Base Distribution, Product Types
        3.4.1 OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers OTC Anti-Infective Products Product Type
        3.4.3 Date of International Manufacturers Enter into OTC Anti-Infective Products Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global OTC Anti-Infective Products Market Size by Type (2016-2021)
        4.1.1 Global OTC Anti-Infective Products Sales by Type (2016-2021)
        4.1.2 Global OTC Anti-Infective Products Revenue by Type (2016-2021)
        4.1.3 OTC Anti-Infective Products Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global OTC Anti-Infective Products Market Size Forecast by Type (2022-2027)
        4.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2022-2027)
        4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2022-2027)
        4.2.3 OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global OTC Anti-Infective Products Market Size by Application (2016-2021)
        5.1.1 Global OTC Anti-Infective Products Sales by Application (2016-2021)
        5.1.2 Global OTC Anti-Infective Products Revenue by Application (2016-2021)
        5.1.3 OTC Anti-Infective Products Price by Application (2016-2021)
    5.2 OTC Anti-Infective Products Market Size Forecast by Application (2022-2027)
        5.2.1 Global OTC Anti-Infective Products Sales Forecast by Application (2022-2027)
        5.2.2 Global OTC Anti-Infective Products Revenue Forecast by Application (2022-2027)
        5.2.3 Global OTC Anti-Infective Products Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
    6.1 China OTC Anti-Infective Products Market Size YoY Growth 2016-2027
        6.1.1 China OTC Anti-Infective Products Sales YoY Growth 2016-2027
        6.1.2 China OTC Anti-Infective Products Revenue YoY Growth 2016-2027
        6.1.3 China OTC Anti-Infective Products Market Share in Global Market 2016-2027
    6.2 China OTC Anti-Infective Products Market Size by Players (International and Local Players)
        6.2.1 China Top OTC Anti-Infective Products Players by Sales (2016-2021)
        6.2.2 China Top OTC Anti-Infective Products Players by Revenue (2016-2021)
    6.3 China OTC Anti-Infective Products Historic Market Review by Type (2016-2021)
        6.3.1 China OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
        6.3.2 China OTC Anti-Infective Products Revenue Market Share by Type (2016-2021)
        6.3.3 China OTC Anti-Infective Products Price by Type (2016-2021)
    6.4 China OTC Anti-Infective Products Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 China OTC Anti-Infective Products Sales Forecast by Type (2022-2027)
        6.4.2 China OTC Anti-Infective Products Revenue Forecast by Type (2022-2027)
        6.4.3 China OTC Anti-Infective Products Price Forecast by Type (2022-2027)
    6.5 China OTC Anti-Infective Products Historic Market Review by Application (2016-2021)
        6.5.1 China OTC Anti-Infective Products Sales Market Share by Application (2016-2021)
        6.5.2 China OTC Anti-Infective Products Revenue Market Share by Application (2016-2021)
        6.5.3 China OTC Anti-Infective Products Price by Application (2016-2021)
    6.6 China OTC Anti-Infective Products Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 China OTC Anti-Infective Products Sales Forecast by Application (2022-2027)
        6.6.2 China OTC Anti-Infective Products Revenue Forecast by Application (2022-2027)
        6.6.3 China OTC Anti-Infective Products Price Forecast by Application (2022-2027)

7 North America
    7.1 North America OTC Anti-Infective Products Market Size YoY Growth 2016-2027
    7.2 North America OTC Anti-Infective Products Market Facts & Figures by Country
        7.2.1 North America OTC Anti-Infective Products Sales by Country (2016-2021)
        7.2.2 North America OTC Anti-Infective Products Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific OTC Anti-Infective Products Market Size YoY Growth 2016-2027
    8.2 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Region
        8.2.1 Asia Pacific OTC Anti-Infective Products Sales by Region (2016-2021)
        8.2.2 Asia Pacific OTC Anti-Infective Products Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe OTC Anti-Infective Products Market Size YoY Growth 2016-2027
    9.2 Europe OTC Anti-Infective Products Market Facts & Figures by Country
        9.2.1 Europe OTC Anti-Infective Products Sales by Country (2016-2021)
        9.2.2 Europe OTC Anti-Infective Products Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America OTC Anti-Infective Products Market Size YoY Growth 2016-2027
    10.2 Latin America OTC Anti-Infective Products Market Facts & Figures by Country
        10.2.1 Latin America OTC Anti-Infective Products Sales by Country (2016-2021)
        10.2.2 Latin America OTC Anti-Infective Products Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa OTC Anti-Infective Products Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Country
        11.2.1 Middle East and Africa OTC Anti-Infective Products Sales by Country (2016-2021)
        11.2.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 GlaxoSmithKline
        12.1.1 GlaxoSmithKline Corporation Information
        12.1.2 GlaxoSmithKline Description and Business Overview
        12.1.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
        12.1.5 GlaxoSmithKline Recent Development
    12.2 Merck
        12.2.1 Merck Corporation Information
        12.2.2 Merck Description and Business Overview
        12.2.3 Merck OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Merck OTC Anti-Infective Products Products Offered
        12.2.5 Merck Recent Development
    12.3 Pfizer
        12.3.1 Pfizer Corporation Information
        12.3.2 Pfizer Description and Business Overview
        12.3.3 Pfizer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Pfizer OTC Anti-Infective Products Products Offered
        12.3.5 Pfizer Recent Development
    12.4 Novartis
        12.4.1 Novartis Corporation Information
        12.4.2 Novartis Description and Business Overview
        12.4.3 Novartis OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Novartis OTC Anti-Infective Products Products Offered
        12.4.5 Novartis Recent Development
    12.5 Abbott
        12.5.1 Abbott Corporation Information
        12.5.2 Abbott Description and Business Overview
        12.5.3 Abbott OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Abbott OTC Anti-Infective Products Products Offered
        12.5.5 Abbott Recent Development
    12.6 Sanofi
        12.6.1 Sanofi Corporation Information
        12.6.2 Sanofi Description and Business Overview
        12.6.3 Sanofi OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Sanofi OTC Anti-Infective Products Products Offered
        12.6.5 Sanofi Recent Development
    12.7 Bristol-Myers Squibb
        12.7.1 Bristol-Myers Squibb Corporation Information
        12.7.2 Bristol-Myers Squibb Description and Business Overview
        12.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered
        12.7.5 Bristol-Myers Squibb Recent Development
    12.8 Roche
        12.8.1 Roche Corporation Information
        12.8.2 Roche Description and Business Overview
        12.8.3 Roche OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Roche OTC Anti-Infective Products Products Offered
        12.8.5 Roche Recent Development
    12.9 NanoViricides
        12.9.1 NanoViricides Corporation Information
        12.9.2 NanoViricides Description and Business Overview
        12.9.3 NanoViricides OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 NanoViricides OTC Anti-Infective Products Products Offered
        12.9.5 NanoViricides Recent Development
    12.10 Novabay Pharmaceuticals
        12.10.1 Novabay Pharmaceuticals Corporation Information
        12.10.2 Novabay Pharmaceuticals Description and Business Overview
        12.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Products Offered
        12.10.5 Novabay Pharmaceuticals Recent Development
    12.11 GlaxoSmithKline
        12.11.1 GlaxoSmithKline Corporation Information
        12.11.2 GlaxoSmithKline Description and Business Overview
        12.11.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
        12.11.5 GlaxoSmithKline Recent Development
    12.12 Basilea Pharmaceutica
        12.12.1 Basilea Pharmaceutica Corporation Information
        12.12.2 Basilea Pharmaceutica Description and Business Overview
        12.12.3 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Basilea Pharmaceutica Products Offered
        12.12.5 Basilea Pharmaceutica Recent Development
    12.13 MerLion Pharma
        12.13.1 MerLion Pharma Corporation Information
        12.13.2 MerLion Pharma Description and Business Overview
        12.13.3 MerLion Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 MerLion Pharma Products Offered
        12.13.5 MerLion Pharma Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 OTC Anti-Infective Products Industry Trends
    13.2 OTC Anti-Infective Products Market Drivers
    13.3 OTC Anti-Infective Products Market Challenges
    13.4 OTC Anti-Infective Products Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 OTC Anti-Infective Products Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Global OTC Anti-Infective Products Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Antifungals Table 3. Major Manufacturers of Antiseptic Table 4. Major Manufacturers of Antiparasitics Table 5. Global OTC Anti-Infective Products Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global OTC Anti-Infective Products Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global OTC Anti-Infective Products Sales by Regions (2016-2021) & (K Units) Table 8. Global OTC Anti-Infective Products Sales Market Share by Regions (2016-2021) Table 9. Global OTC Anti-Infective Products Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global OTC Anti-Infective Products Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global OTC Anti-Infective Products Sales Market Share Forecast by Region (2022-2027) Table 12. Global OTC Anti-Infective Products Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global OTC Anti-Infective Products Revenue Market Share Forecast by Region (2022-2027) Table 14. Global OTC Anti-Infective Products Sales by Manufacturers (2016-2021) (K Units) Table 15. Global OTC Anti-Infective Products Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top OTC Anti-Infective Products Manufacturers by Revenue (US$ Million) in 2020 Table 17. OTC Anti-Infective Products Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. OTC Anti-Infective Products Revenue Share by Manufacturers (2016-2021) Table 19. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Anti-Infective Products as of 2020) Table 21. Key Manufacturers OTC Anti-Infective Products Price (2016-2021) (USD/Unit) Table 22. OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers OTC Anti-Infective Products Product Type Table 24. Date of International Manufacturers Enter into OTC Anti-Infective Products Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global OTC Anti-Infective Products Sales by Type (2016-2021) (K Units) Table 27. Global OTC Anti-Infective Products Sales Share by Type (2016-2021) Table 28. Global OTC Anti-Infective Products Revenue by Type (2016-2021) (US$ Million) Table 29. Global OTC Anti-Infective Products Revenue Share by Type (2016-2021) Table 30. OTC Anti-Infective Products Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 31. Global OTC Anti-Infective Products Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global OTC Anti-Infective Products Sales Market Share Forecast by Type (2022-2027) Table 33. Global OTC Anti-Infective Products Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global OTC Anti-Infective Products Revenue Market Share Forecast by Type (2022-2027) Table 35. Global OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 36. Global OTC Anti-Infective Products Sales by Application (2016-2021) (K Units) Table 37. Global OTC Anti-Infective Products Sales Share by Application (2016-2021) Table 38. Global OTC Anti-Infective Products Revenue by Application (2016-2021) (US$ Million) Table 39. Global OTC Anti-Infective Products Revenue Share by Application (2016-2021) Table 40. OTC Anti-Infective Products Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 41. Global OTC Anti-Infective Products Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global OTC Anti-Infective Products Sales Market Share Forecast by Application (2022-2027) Table 43. Global OTC Anti-Infective Products Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global OTC Anti-Infective Products Revenue Market Share Forecast by Application (2022-2027) Table 45. Global OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 46. China OTC Anti-Infective Products Sales (K Units) of Key Companies (2016-2021) Table 47. China OTC Anti-Infective Products Sales Share by Company (2016-2021) Table 48. China OTC Anti-Infective Products Revenue (US$ Million) by Company (2016-2021) Table 49. China OTC Anti-Infective Products Revenue Share by Company (2016-2021) Table 50. China OTC Anti-Infective Products Sales (K Units) by Type (2016-2021) Table 51. China OTC Anti-Infective Products Sales Share by Type (2016-2021) Table 52. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China OTC Anti-Infective Products Price (USD/Unit) by Type (2016-2021) Table 54. China OTC Anti-Infective Products Sales (K Units) by Type (2022-2027) Table 55. China OTC Anti-Infective Products Sales Share by Type (2022-2027) Table 56. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China OTC Anti-Infective Products Revenue Share by Type (2022-2027) Table 58. China OTC Anti-Infective Products Price (USD/Unit) by Type (2022-2027) Table 59. China OTC Anti-Infective Products Sales (K Units) by Application (2016-2021) Table 60. China OTC Anti-Infective Products Sales Share by Application (2016-2021) Table 61. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China OTC Anti-Infective Products Price (USD/Unit) by Application (2016-2021) Table 63. China OTC Anti-Infective Products Sales (K Units) by Application (2022-2027) Table 64. China OTC Anti-Infective Products Sales Share by Application (2022-2027) Table 65. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China OTC Anti-Infective Products Revenue Share by Application (2022-2027) Table 67. China OTC Anti-Infective Products Price (USD/Unit) by Application (2022-2027) Table 68. North America OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units) Table 69. North America OTC Anti-Infective Products Sales Market Share by Country (2016-2021) Table 70. North America OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million) Table 71. North America OTC Anti-Infective Products Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific OTC Anti-Infective Products Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2016-2021) Table 74. Asia Pacific OTC Anti-Infective Products Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2016-2021) Table 76. Europe OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units) Table 77. Europe OTC Anti-Infective Products Sales Market Share by Country (2016-2021) Table 78. Europe OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe OTC Anti-Infective Products Revenue Market Share by Country (2016-2021) Table 80. Latin America OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units) Table 81. Latin America OTC Anti-Infective Products Sales Market Share by Country (2016-2021) Table 82. Latin Americaa OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2016-2021) Table 88. GlaxoSmithKline Corporation Information Table 89. GlaxoSmithKline Description and Business Overview Table 90. GlaxoSmithKline OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. GlaxoSmithKline OTC Anti-Infective Products Product Table 92. GlaxoSmithKline Recent Development Table 93. Merck Corporation Information Table 94. Merck Description and Business Overview Table 95. Merck OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Merck Product Table 97. Merck Recent Development Table 98. Pfizer Corporation Information Table 99. Pfizer Description and Business Overview Table 100. Pfizer OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Pfizer Product Table 102. Pfizer Recent Development Table 103. Novartis Corporation Information Table 104. Novartis Description and Business Overview Table 105. Novartis OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Novartis Product Table 107. Novartis Recent Development Table 108. Abbott Corporation Information Table 109. Abbott Description and Business Overview Table 110. Abbott OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Abbott Product Table 112. Abbott Recent Development Table 113. Sanofi Corporation Information Table 114. Sanofi Description and Business Overview Table 115. Sanofi OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Sanofi Product Table 117. Sanofi Recent Development Table 118. Bristol-Myers Squibb Corporation Information Table 119. Bristol-Myers Squibb Description and Business Overview Table 120. Bristol-Myers Squibb OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Bristol-Myers Squibb Product Table 122. Bristol-Myers Squibb Recent Development Table 123. Roche Corporation Information Table 124. Roche Description and Business Overview Table 125. Roche OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Roche Product Table 127. Roche Recent Development Table 128. NanoViricides Corporation Information Table 129. NanoViricides Description and Business Overview Table 130. NanoViricides OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. NanoViricides Product Table 132. NanoViricides Recent Development Table 133. Novabay Pharmaceuticals Corporation Information Table 134. Novabay Pharmaceuticals Description and Business Overview Table 135. Novabay Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Novabay Pharmaceuticals Product Table 137. Novabay Pharmaceuticals Recent Development Table 138. Optimer Pharmaceuticals Corporation Information Table 139. Optimer Pharmaceuticals Description and Business Overview Table 140. Optimer Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 141. Optimer Pharmaceuticals Product Table 142. Optimer Pharmaceuticals Recent Development Table 143. Basilea Pharmaceutica Corporation Information Table 144. Basilea Pharmaceutica Description and Business Overview Table 145. Basilea Pharmaceutica OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 146. Basilea Pharmaceutica Product Table 147. Basilea Pharmaceutica Recent Development Table 148. MerLion Pharma Corporation Information Table 149. MerLion Pharma Description and Business Overview Table 150. MerLion Pharma OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 151. MerLion Pharma Product Table 152. MerLion Pharma Recent Development Table 153. OTC Anti-Infective Products Market Trends Table 154. OTC Anti-Infective Products Market Drivers Table 155. OTC Anti-Infective Products Market Challenges Table 156. OTC Anti-Infective Products Market Restraints Table 157. OTC Anti-Infective Products Customers List Table 158. OTC Anti-Infective Products Distributors List Table 159. Research Programs/Design for This Report Table 160. Key Data Information from Secondary Sources Table 161. Key Data Information from Primary Sources List of Figures Figure 1. OTC Anti-Infective Products Product Picture Figure 2. Global OTC Anti-Infective Products Sales Market Share by Type in 2020 & 2027 Figure 3. Antifungals Product Picture Figure 4. Antiseptic Product Picture Figure 5. Antiparasitics Product Picture Figure 6. Global OTC Anti-Infective Products Sales Market Share by Application in 2020 & 2027 Figure 7. Hospital Pharmacies Figure 8. Drug Stores Figure 9. Retail Stores Figure 10. E-Commerce Figure 11. OTC Anti-Infective Products Report Years Considered Figure 12. Global OTC Anti-Infective Products Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global OTC Anti-Infective Products Market Size 2016-2027 (US$ Million) Figure 14. Global OTC Anti-Infective Products Sales 2016-2027 (K Units) Figure 15. Global OTC Anti-Infective Products Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global OTC Anti-Infective Products Sales Market Share by Region (2016-2021) Figure 17. Global OTC Anti-Infective Products Sales Market Share by Region in 2020 Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Region (2016-2021) Figure 19. Global OTC Anti-Infective Products Revenue Market Share by Region in 2020 Figure 20. Global OTC Anti-Infective Products Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by OTC Anti-Infective Products Revenue in 2020 Figure 22. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global OTC Anti-Infective Products Sales Market Share by Type (2016-2021) Figure 24. Global OTC Anti-Infective Products Sales Market Share by Type in 2020 Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2021) Figure 26. Global OTC Anti-Infective Products Revenue Market Share by Type in 2020 Figure 27. Global OTC Anti-Infective Products Sales Market Share by Application (2016-2021) Figure 28. Global OTC Anti-Infective Products Sales Market Share by Application in 2020 Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Application (2016-2021) Figure 30. Global OTC Anti-Infective Products Revenue Market Share by Application in 2020 Figure 31. China OTC Anti-Infective Products Sales Growth Rate 2016-2027 (K Units) Figure 32. China OTC Anti-Infective Products Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. China OTC Anti-Infective Products Market Share in Global Market 2016-2027 Figure 34. China 5 and 10 Largest OTC Anti-Infective Products Players Market Share by Revenue in OTC Anti-Infective Products in 2020 Figure 35. China OTC Anti-Infective Products Revenue Share by Type (2016-2021) Figure 36. China OTC Anti-Infective Products Revenue Growth Rate by Type in 2016 & 2020 Figure 37. China OTC Anti-Infective Products Revenue Share by Application (2016-2021) Figure 38. China OTC Anti-Infective Products Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America OTC Anti-Infective Products Sales Growth Rate 2016-2021 (K Units) Figure 40. North America OTC Anti-Infective Products Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America OTC Anti-Infective Products Sales Market Share by Country in 2020 Figure 42. North America OTC Anti-Infective Products Revenue Market Share by Country in 2020 Figure 43. U.S. OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 44. U.S. OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe OTC Anti-Infective Products Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe OTC Anti-Infective Products Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe OTC Anti-Infective Products Sales Market Share by Country in 2020 Figure 50. Europe OTC Anti-Infective Products Revenue Market Share by Country in 2020 Figure 51. Germany OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 54. France OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific OTC Anti-Infective Products Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific OTC Anti-Infective Products Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region in 2020 Figure 64. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region in 2020 Figure 65. China OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 66. China OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 72. India OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 76. Taiwan OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 84. Philippines OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 86. Vietnam OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America OTC Anti-Infective Products Sales Growth Rate 2016-2021 (K Units) Figure 88. Latin America OTC Anti-Infective Products Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America OTC Anti-Infective Products Sales Market Share by Country in 2020 Figure 90. Latin America OTC Anti-Infective Products Revenue Market Share by Country in 2020 Figure 91. Mexico OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 92. Mexico OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 94. Brazil OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 96. Argentina OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa OTC Anti-Infective Products Sales Growth Rate 2016-2021 (K Units) Figure 98. Middle East and Africa OTC Anti-Infective Products Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country in 2020 Figure 100. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country in 2020 Figure 101. Turkey OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 102. Turkey OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 104. Saudi Arabia OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. U.A.E OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units) Figure 106. U.A.E OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. OTC Anti-Infective Products Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us